US equities |
NVDA $236.95 ▲+1.28% SPCX $165.02 ▲+3.81% MU $1,064.89 ▼-0.93% TSLA $378.58 ▲+2.16% MSFT $526.57 ▲+1.75% INTC $116.97 ▼-1.98% SNDK $1,723.63 ▲+0.21% AMD $628.42 ▼-0.87%
FinancialContent

Chemed Corp (NY:CHE)

505.30 -2.20 (-0.43%)
Delayed Quote Updated: 10:11 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemed Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
5 Revealing Analyst Questions From Chemed’s Q1 Earnings Call
Chemed’s first quarter results were well received by the market, reflecting stronger-than-expected performance at its VITAS hospice business and early signs ... 
Via StockStory
Topics Earnings
News headline image
Why Chemed (CHE) Stock Is Up Today
What Happened? Shares of healthcare services company Chemed Corporation (NYSE:CHE) jumped 8.8% in the afternoon session after the company reported first-quar... 
Via StockStory
Topics Earnings
News headline image
CHE Q1 Deep Dive: VITAS Drives Growth, Roto-Rooter Adapts to Higher Marketing Costs
Healthcare services company Chemed Corporation (NYSE:CHE) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 1.6% year on ye... 
Via StockStory
News headline image
Chemed (CHE) Q1 2026 Earnings Call Transcript ↗
Chemed (CHE) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Chemed Corp (NYSE:CHE) Soars on Q1 Beat and Raised Full-Year Guidance ↗
Via Chartmill
Chemed Corp. (NYSE:CHE) Shares Drop on Q4 Earnings and Revenue Miss ↗
Via Chartmill
News headline image
Chemed’s (NYSE:CHE) Q1 CY2026 Sales Top Estimates, Stock Jumps 10.2%
Healthcare services company Chemed Corporation (NYSE:CHE) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 1.6% year on year to $657.5 mil... 
Via StockStory
News headline image
Chemed Reports First-Quarter 2026 Results
From Chemed Corp.
Via GlobeNewswire
News headline image
Chemed (CHE) Q1 Earnings: What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be announcing earnings results this Thursday after market close. Here’s what investors should ... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Cash-Producing Stocks We’re Skeptical Of
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
Via StockStory
News headline image
Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement
From Chemed Corp.
Via GlobeNewswire
News headline image
Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24
From Chemed Corp.
Via GlobeNewswire
News headline image
Roto-Rooter Completes Acquisitions for Two Significant Territories
From Chemed Corp.
Via GlobeNewswire
News headline image
1 Profitable Stock on Our Buy List and 2 We Ignore
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
Q4 Earnings Outperformers: Chemed (NYSE:CHE) And The Rest Of The Senior Health, Home Health & Hospice Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the senior health, home health & hospice stocks, including Chemed (NYSE:CHE) and its pe... 
Via StockStory
Topics Economy
News headline image
3 Out-of-Favor Stocks Walking a Fine Line
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet... 
Via StockStory
News headline image
3 Reasons to Sell CHE and 1 Stock to Buy Instead
Over the past six months, Chemed’s shares (currently trading at $402.72) have posted a disappointing 11.9% loss while the S&P 500 was flat. This was partly d... 
Via StockStory
Topics Stocks
News headline image
1 Unpopular Stock That Deserves Some Love and 2 We Find Risky
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
News headline image
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference
From Chemed Corp.
Via GlobeNewswire
News headline image
Why Chemed (CHE) Shares Are Plunging Today
Shares of healthcare services company Chemed Corporation (NYSE:CHE) fell 15.6% in the afternoon session after the company reported financial results for the fourth quarter of 2025 that missed Wall... 
Via StockStory
News headline image
Chemed (CHE) Q4 2025 Earnings Call Transcript ↗
Chemed (CHE) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Chemed (NYSE:CHE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops 14.7%
Healthcare services company Chemed Corporation (NYSE:CHE) fell short of the market’s revenue expectations in Q4 CY2025, with sales flat year on year at $639.3 million. Its non-GAAP profit of $6.42 per... 
Via StockStory
News headline image
Chemed Reports Fourth-Quarter 2025 Results
From Chemed Corp.
Via GlobeNewswire
News headline image
Chemed (CHE) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting earnings this Wednesday afternoon. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
1 Cash-Producing Stock to Consider Right Now and 2 We Find Risky
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Topics Economy
News headline image
3 Reasons to Sell CHE and 1 Stock to Buy Instead
Chemed trades at $473.22 per share and has stayed right on track with the overall market, gaining 6.4% over the last six months. At the same time, the S&P 500 has returned 6%. 
Via StockStory
Topics Stocks
News headline image
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake ↗
Chemed Corporation delivers hospice care and essential home services nationwide through its VITAS and Roto-Rooter segments. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents
From Chemed Corp.
Via GlobeNewswire
News headline image
1 Profitable Stock on Our Watchlist and 2 That Underwhelm
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
3 Healthcare Stocks We Steer Clear Of
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.6% over... 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9 10 Next >